Abstract:
PURPOSE: Novel lactic acid bacteria, Lactobacillus salivarius, which suppress antibiotic resistant Staphylococcus and Salmonella isolated from poultry excreta is provided to prevent pathogens from being infected to humans through livestock or livestock food products, and to be used in various fields such as probiotics and health functional foods. CONSTITUTION: Lactobacillus salivarius (deposit number: KACC 91656) has 16 rRNA of sequence number 1. The strain suppresses antibiotic resistant Staphylococcus and Salmonella. Probiotics contain the strain. A method for identifying a strain which suppresses antibiotic resistant Staphylococcus and Salmonella isolated from poultry excreta comprises the steps of: collecting the poultry excreta; isolating strains; checking the activity of antibiotics in the isolated strains; and identifying base sequences of the isolated strains. [Reference numerals] (AA) Collect poultry excreta and isolate lactic acid bacteria; (BB) Isolate lactic acid bacteria which excellently suppress antibiotic resistant Staphylococcus; (CC) Isolate lactic acid bacteria which excellently suppress salmonella; (DD) Isolate antibacterial materials and confirm an antibacterial effect; (EE) Identify strains; (FF) Confirm novelty
Abstract:
PURPOSE: A composition for improving cognitive ability and a method for manufacturing the same are provided to develop anti-dementia material using pork rind. CONSTITUTION: A composition for improving cognitive ability contains gelatin-derived enzymatic lysate as an active ingredient. The gelatin is derived from pork rind. The enzyme is alcalase, protamex, or flavorzyme. A method for preparing the composition comprises: a step of hydrolyzing gelatin to prepare a gelatin solution; a step of adding enzyme to the gelatin solution and performing lysis at pH 6-9 and 30-60°C for 2-24 hours; and a step of desalting the enzyme lysate.
Abstract:
PURPOSE: A Weissella viridescens with MRSA(methicillin-resistant Staphylococcus aureus) suppression ability is provided to enhance health of human body and livestock. CONSTITUTION: A Weissella viridescens 2-T-2-20(deposit number KACC91550) has an ability of suppressing MRSA. A probiotic composition contains the bacteria or culture liquid thereof as an active ingredient. The probiotic composition is used as an additive for feed or food. The probiotic composition is a pharmaceutical composition containing a pharmaceutical carrier and excipient.
Abstract:
PURPOSE: An Enterococcus faecalis KACC91532P and a fermentation product containing the same are provided to promote bacteria proliferation. CONSTITUTION: An Enterococcus faecalis KACC91532P has effect of normalizing gut microbiota. A fermentation product contains the strain or culture thereof. The fermentation product includes fermented milk, baby food, or patient food. The fermentation product contains perfume, sweetening agent, bifidobacterium, or preservative. A method for producing the fermentation product comprises a step of adding the strain or culture thereof and lactic acid bacterium starter to daily products and fermenting.